<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">inovmed</journal-id><journal-title-group><journal-title xml:lang="ru">Инновационная медицина Кубани</journal-title><trans-title-group xml:lang="en"><trans-title>Innovative Medicine of Kuban</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2541-9897</issn><publisher><publisher-name>Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">inovmed-156</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>CЛУЧАЙ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>СASE REPORTS</subject></subj-group></article-categories><title-group><article-title>СЕМЕЙНАЯ ГИПЕРХОЛЕСТЕРИНЕМИЯ В КРАСНОДАРСКОМ КРАЕ: ПРОБЛЕМЫ И ВОЗМОЖНЫЕ ПУТИ ИХ РЕШЕНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>FAMILY HYPERCHOLESTEREMIA IN KRASNODAR REGION: ISSUES AND HOW TO SOLVE THEM</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5866-506X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Намитоков</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Namitokov</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, заведующий кардиологическим отделением № 2 для больных с инфарктом миокарда </p><p>350086, Краснодар, ул. 1 Мая, 167</p></bio><bio xml:lang="en"><p>Head of cardiology department no. 2 </p><p>350086, Krasnodar, 167, 1st May street</p></bio><email xlink:type="simple">namitokov.alim@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3883-8696</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зафираки</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Zafiraki</surname><given-names>V. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент кафедры терапии № 1 ФПК и ППС</p></bio><bio xml:lang="en"><p>Assistant professor of Therapy Department no. 1 FAT</p></bio><email xlink:type="simple">vzaphir@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1468-5074</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фетисова</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Fetisova</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Клинический ординатор кафедры кардиохирургии и кардиологии ФПК и ППС</p></bio><bio xml:lang="en"><p>Clinical Resident of the Department of Cardiac Surgery and Cardiology</p></bio><email xlink:type="simple">valmel93@ya.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8600-0199</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Космачёва</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosmacheva</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, заместитель главного врача по лечебной работе, НИИ – Краевая клиническая больница № 1 им. проф. С.В. Очаповского, заведeющая кафедрой терапии № 1 ФФК и ППС КубГМУ</p></bio><bio xml:lang="en"><p>Dr. of Sci. (Med.), chief medical officer, Scientific Research Institute – Ochapovsky Regional Clinic Hospital no. 1, head of Department of therapy no. 1 ATF, Kuban State Medical University</p></bio><email xlink:type="simple">Kosmachova_h@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт – Краевая клиническая больница № 1 им. проф. С.В. Очаповского Министерства здравоохранения Краснодарского края</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Кубанский государственный медицинский университет Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт – Краевая клиническая больница № 1 им. проф. С.В. Очаповского Министерства здравоохранения Краснодарского края; Кубанский государственный медицинский университет Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1; &#13;
Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2019</year></pub-date><volume>0</volume><issue>1</issue><fpage>57</fpage><lpage>63</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Намитоков А.М., Зафираки В.К., Фетисова В.И., Космачёва Е.Д., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Намитоков А.М., Зафираки В.К., Фетисова В.И., Космачёва Е.Д.</copyright-holder><copyright-holder xml:lang="en">Namitokov A.M., Zafiraki V.K., Fetisova V.I., Kosmacheva E.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.innovmedkub.ru/jour/article/view/156">https://www.innovmedkub.ru/jour/article/view/156</self-uri><abstract><p>Коронарная хирургия и эндоваскулярные коронарные вмешательства позволили существенно снизить смертность и инвалидизацию от острых и хронических форм ишемической болезни сердца в Краснодарском крае. В поисках путей по дальнейшему улучшению этих показателей больше внимания стало уделяться вопросам своевременного выявления факторов риска атеросклеротических сердечно-сосудистых заболеваний (АССЗ) и их первичной профилактики, особенно среди работоспособного населения. С этих позиций семейная гиперхолестеринемия (СГХС) как заболевание, связанное с очень высоким риском АССЗ, причем часто в молодом возрасте, является одной из значимых точек приложения усилий по профилактике заболеваемости и смертности от АССЗ. В последние годы на основании выполненных эпидемиологических и регистровых исследований произошел существенный пересмотр представлений о распространенности СГХС, в результате данное заболевание считается не столь уж редким: ~1:200 1:250 в общей популяции. Низкая осведомленность среди населения и врачей о СГХС в России и Краснодарском крае, крайне низкая выявляемость, отсутствие представлений о реальной распространенности этой патологии приводят к тому, что больным столь серьезным по своему неблагоприятному прогнозу заболеванием очень редко устанавливается правильный диагноз и проводится современное лечение, способное в корне изменить течение заболевания.</p><p>В статье освещаются современные подходы к диагностике и лечению СГХС, приводятся клинические случаи из собственной клинической практики, а также обсуждаются возможные шаги по организации своевременного выявления и лечения СГХС.</p></abstract><trans-abstract xml:lang="en"><p>Coronary surgery and endovascular coronary interventions allowed significantly reduce mortality and an invalidization caused by sharp and chronic forms of coronary heart disease in Krasnodar Region. Searching ways for further improvement of these indicators we start paying more attention to problems of timely identification of risk factors in cases with atherosclerotic cardiovascular diseases (ACD) and their primary prevention, especially among the efficient labor pool.</p><p>From this point of view family hypercholesterolemia (SGHS) as a disease connected with a very high risk of ACD and frequently at young age, is one of the significant points of effort application for prevention of incidence and mortality from ACD. In recent years on the basis of the executed epidemiological and register researches there was a significant revision of ideas on possible prevalence of SGHS, as a result this disease is considered not to be so rare: ~ 1:200–1:250 in a general population. Low awareness among the population and physicians on SGHS in Russia and Krasnodar Region, its extremely low detection frequency, lack of information about real prevalence of this pathology lead to the fact that the correct diagnosis is very seldom verified, and modern treatment which is capable to change the course of a disease is carried out.</p><p>Modern approaches of diagnosis and treatment for SGHS are presented in this article, clinical cases from own clinical practice are described and also, we discuss possible steps on the organization of timely identification and treatment of SGHS.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>атеросклероз</kwd><kwd>семейная гиперхолестеринемия</kwd><kwd>инфаркт</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atherosclerosis</kwd><kwd>family hypercholesteremia</kwd><kwd>infarction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Iacocca MA, Chora JR, Carrié A, Freiberger T, Leigh SE, еt al. ClinVar database of global familial hypercholesterolemia-associated DNA variants. HumMutat. 2018:39(11):1631-1640.</mixed-citation><mixed-citation xml:lang="en">Iacocca MA, Chora JR, Carrié A, Freiberger T, Leigh SE, еt al. ClinVar database of global familial hypercholesterolemia-associated DNA variants. HumMutat. 2018:39(11):1631-1640.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rader DJ, Cohen J, Hobbs HH. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J. Clin. Invest. 2003;111:1795-1803. DOI: https://doi.org/10.1172/jci200318925</mixed-citation><mixed-citation xml:lang="en">Rader DJ, Cohen J, Hobbs HH. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J. Clin. Invest. 2003;111:1795-1803. DOI: https://doi.org/10.1172/jci200318925</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Титов В.Н., Востров И.А., Каба С.И. и др. Липопротеины низкой очень низкой плотности: патогенетическое и клиническое значение. Клиническая медицина. 2013;1:20-27.</mixed-citation><mixed-citation xml:lang="en">Titov V.N., Vostrov I.A., Kaba S.I. et al. Very low density lipoprotein: pathogenesis and clinical significance. Clinical medicine. 2013;1:20-27. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459-2472. DOI: https://doi.org/10.1093/eurheartj/ehx144</mixed-citation><mixed-citation xml:lang="en">Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459-2472. DOI: https://doi.org/10.1093/eurheartj/ehx144</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Benn M, Watts GF, Tybjaerg-Hansen А, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab. 2012;97(11):3956-3964. DOI: https://doi.org/10.1210/jc.2012-1563</mixed-citation><mixed-citation xml:lang="en">Benn M, Watts GF, Tybjaerg-Hansen А, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab. 2012;97(11):3956-3964. DOI: https://doi.org/10.1210/jc.2012-1563</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cuchel M, Bruckert Е, Ginsberg HN, Raal FJ, Santos RD, et al. European atherosclerosis society consensus panel on familial hypercholesterolaemia. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the european atherosclerosis society. Eur. Heart J. 2014;35(32):2146-2157.</mixed-citation><mixed-citation xml:lang="en">Cuchel M, Bruckert Е, Ginsberg HN, Raal FJ, Santos RD, et al. European atherosclerosis society consensus panel on familial hypercholesterolaemia. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the european atherosclerosis society. Eur. Heart J. 2014;35(32):2146-2157.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ershova AI, Meshkov AN, Bazhan SS, Storozhok MA, Efanov AY, et al. The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF. PLoS One. 2017;12(7):e0181148. DOI: https://doi.org/10.1371/journal.pone.0181148</mixed-citation><mixed-citation xml:lang="en">Ershova AI, Meshkov AN, Bazhan SS, Storozhok MA, Efanov AY, et al. The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF. PLoS One. 2017;12(7):e0181148. DOI: https://doi.org/10.1371/journal.pone.0181148</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ежов М.В., Сергиенко И.В., Дупляков Д.В., Абашина О.Е., Качковский М.А. и др. Российские рекомендации по диагностике и лечению семейной гиперхолестеринемии. Атеросклероз и дислипидемии. 2016;4:21-29.</mixed-citation><mixed-citation xml:lang="en">Ezhov MV, Sergienko IV, Duplyakov DV, Abashina OE, Kachkovskii MA, et al. Russian recommendations for the diagnosis and treatment of familial hypercholesterolemia. Atherosclerosis and dyslipidemia. 2016;4:21-29. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, et al. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. J. ClinLipidol. 2014;8(2):148-172.</mixed-citation><mixed-citation xml:lang="en">Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, et al. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. J. ClinLipidol. 2014;8(2):148-172.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson GR, Blom DJ, Marais AD, Seed M, Pilcher GJ, et al. Survival in homozygous familial hypercholesterolemia is determined by the on-treatment level of serum cholesterol. Eur. Heart J. 2018;39:11621168. DOI: https://doi.org/10.1093/eurheartj/ehx317</mixed-citation><mixed-citation xml:lang="en">Thompson GR, Blom DJ, Marais AD, Seed M, Pilcher GJ, et al. Survival in homozygous familial hypercholesterolemia is determined by the on-treatment level of serum cholesterol. Eur. Heart J. 2018;39:11621168. DOI: https://doi.org/10.1093/eurheartj/ehx317</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis. 1999;142:105-112. DOI: https://doi.org/10.1016/s00219150(98)00200-7</mixed-citation><mixed-citation xml:lang="en">Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis. 1999;142:105-112. DOI: https://doi.org/10.1016/s00219150(98)00200-7</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Neil A, Cooper J, Betteridge J, Capps N, McDowell I, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29:2625-2633. DOI: https://doi.org/10.1093/eurheartj/ehn422</mixed-citation><mixed-citation xml:lang="en">Neil A, Cooper J, Betteridge J, Capps N, McDowell I, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29:2625-2633. DOI: https://doi.org/10.1093/eurheartj/ehn422</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Galema-Boers AM, Lenzen MJ, Engelkes SR, Sijbrands EJ, Roeters van Lennep JE. Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy. J. Clin Lipidol. 2018; 12(2):409-416. DOI: https://doi.org/10.1016/j.jacl.2017.12.014</mixed-citation><mixed-citation xml:lang="en">Galema-Boers AM, Lenzen MJ, Engelkes SR, Sijbrands EJ, Roeters van Lennep JE. Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy. J. Clin Lipidol. 2018; 12(2):409-416. DOI: https://doi.org/10.1016/j.jacl.2017.12.014</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chhatriwalla AK, Nicholls SJ, Nissen SE. The ASTEROID trial: coronary plaque regression with highdose statin therapy. Future Cardiol. 2006;2(6):651-654. DOI: https://doi.org/10.2217/14796678.2.6.651</mixed-citation><mixed-citation xml:lang="en">Chhatriwalla AK, Nicholls SJ, Nissen SE. The ASTEROID trial: coronary plaque regression with highdose statin therapy. Future Cardiol. 2006;2(6):651-654. DOI: https://doi.org/10.2217/14796678.2.6.651</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. European Heart Journal. 2015;35:1-4.</mixed-citation><mixed-citation xml:lang="en">Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. European Heart Journal. 2015;35:1-4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
